Analytical Data
-
Gene name
TAFA1/FAM19A1
-
简介
The Dll3 protein is a transmembrane ligand that plays a critical role in regulating cell differentiation and patterning during embryonic development. It participates in the Notch signaling pathway and helps determine cell fate. TAFA1/FAM19A1 Protein, Human is the recombinant human-derived TAFA1/FAM19A1 protein, expressed by E. coli , with tag free.
- Application
-
Species
Human
-
Source
E. coli
-
Tag
Tag Free
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q7Z5A9
-
Expression Region
S26-T133
-
Protein Length
Partial
-
Molecular Weight
12.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TAFA1, also known as FAM19A1, is a member of the TAFA family of proteins characterized by their unique structure and functional properties. Initially identified in the context of immune responses, TAFA1 is primarily expressed in the nervous system and plays a crucial role in neuroinflammation and neural development. Recent studies have suggested that TAFA1 may be involved in modulating the activity of immune cells and influencing inflammatory pathways, thus making it a potential target for therapeutic interventions in various neurological and inflammatory diseases. Furthermore, its expression patterns in different tissues raise questions about its potential roles in cellular signaling and intercellular communication. The recombinant expression of TAFA1 enables researchers to investigate its molecular interactions, elucidate its biological functions, and explore its implications in health and disease. Understanding the precise mechanisms of TAFA1 can provide valuable insights into its contributions to neuroinflammatory processes and may pave the way for novel therapeutic strategies targeting conditions like neurodegeneration or chronic inflammatory disorders. As the field of neuroimmunology continues to evolve, the study of TAFA1/FAM19A1 stands out as a pivotal area of research in understanding the interplay between the nervous and immune systems.
